Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure.

Francia P, Balla C, Uccellini A, Ricotta A, Modestino A, Frattari A, Salvati A, Volpe M. Low-dose angiotensin receptor blockers as an alternative to ACE-inhibitors increase the risk of appropriate ICD interventions in heart failure. Int J Cardiol. 2010 Dec 03; 145(3):522-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.